CC1(C)O[C@@H]2[C@@H](COS(=O)(=O)[O-])O[C@@H](n3ccc(=O)[nH]c3=O)[C@@H]2O1.[K+]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?